Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales Medical Dialogues Bureau7 Sept 2019 9:15 AM ISTRoche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
Pfizer gets USFDA nod for biosimilar to Rituximab Medical Dialogues Bureau25 July 2019 8:59 AM ISTRuxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 9:30 AM ISTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
Roche lymphoma drug drives high remission rate, longer survival: study Ruby Khatun Khatun12 Dec 2017 10:00 AM ISTAn experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced,...
Roche drug cocktail doubles chance of holding lung cancer at bay Ruby Khatun Khatun9 Dec 2017 9:45 AM ISTZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
Roche, AbbVie leukemia drug superior to older medicine in study Ruby Khatun Khatun24 Nov 2017 9:45 AM ISTPatients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
FDA backs Roche Gazyva in first-line follicular lymphoma Ruby Khatun Khatun20 Nov 2017 9:30 AM ISTZURICH: The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma,...
Roche eye drug fails late-stage trial in blow to pipeline Ruby Khatun Khatun11 Sept 2017 9:32 AM ISTZURICH: A drug Roche had hoped would prevent loss of vision and become a big seller failed a late-stage trial, leading some analysts to say on Friday...
Europe ready to embrace first copies of biotech cancer drugs supriya kashyap kashyap17 Feb 2017 12:25 PM ISTLondon : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...
